| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025223 |
| Receipt No. | R000029015 |
| Official scientific title of the study | Growth Hormone (GH) Replacement Therapy Decreased Plasma Diacron-reactive Oxygen Metabolites levels and subsequently, improved Endothelial Function as Assessed by Peripheral Arterial Tonometry in Japanese Patient with growth Hormone deficiency |
| Date of disclosure of the study information | 2017/02/01 |
| Last modified on | 2017/10/16 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Growth Hormone (GH) Replacement Therapy Decreased Plasma Diacron-reactive Oxygen Metabolites levels and subsequently, improved Endothelial Function as Assessed by Peripheral Arterial Tonometry in Japanese Patient with growth Hormone deficiency | |
| Title of the study (Brief title) | The effect of GH replacement therapy | |
| Region |
|
|
| Condition | ||
| Condition | Growth Hormone Deficiency | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of the present study was to elucidate the effect of growth hormone (GH) replacement therapy on diacron-reactive Oxygen Metabolites levels (d-ROMs) and endothelial function by peripheral arterial tonometry in Japanese patients with GH deficiency. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The changes in endothelial function and oxidative stress after GH replacement therapy |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patients with GH dificiency who unreceived GH replacement therapy were enrolled.
Endothelial function by reactive hyperaemia index(RHI; EndoPAT system), d-ROMS, blood pressure, fasting lipids. Plasma GH levels and insulin-like growth factor -1 were also measured at baseline and following GH replacement after 24 weeks. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | GH deficient hypopituitary subjects | |||
| Key exclusion criteria | 1.type 1 or 2 diabetes,
2.severe liver dysfunction 3.severe infections 4.pregnant or nursing women and those who might be pregnant 5.malignancy or the history of malignancy 6.alcoholism 7 any patients whom the investigators judged to be inappropriate for this study. |
|||
| Target sample size | 15 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshimasa Aso |
| Organization | Dokkyo Medical University |
| Division name | Endocrinology and Metabolism |
| Address | 880 Kita-Kobayashi, Mibu, Shimotsuga, Tochigi, Japan |
| TEL | 0282-86-1111 |
| yaso@dokkyomed.ac.jp | |
| Public contact | |
| Name of contact person | Chie Aoki |
| Organization | Dokkyo Medical University |
| Division name | Endocrinology and Metabolism |
| Address | 880 Kita-Kobayashi, Mibu, Shimotsuga, Tochigi, Japan |
| TEL | 0282-86-1111 |
| Homepage URL | |
| c-aoki@dokkyomed.ac.jp | |
| Sponsor | |
| Institute | Dokkyo Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Dokkyo Medical University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029015 |